UK Statutory Instrument SI 2025/1249 United Kingdom

The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025

Enforced by
GPhC
Status
In Force

What it defines

Regulations creating concrete business duties or carrying penalties, grouped as the instrument is structured. Titles link to the source text — blue means you’re leaving for legislation.gov.uk.

Part 1

Introductory Provisions

0 of 3 sections shown
3 other sections in this Part — procedural and definitional
s.art001 Citation and commencement
s.art002 Extent
s.art003 Privy Council procedures and legislative procedures
Part 2

Authorisation by a Pharmacist and, in Great Britain, Supervision by a Pharmacy Technician

0 of 5 sections shown
5 other sections in this Part — procedural and definitional
s.art004 Exemption from requirement for manufacturer’s licence or marketing authorisation: authorisation of a pharmacist
s.art005 Exemption from the requirement for manufacturer’s licence or marketing authorisation: registered pharmacy technicians at hospital aseptic facilities
s.art006 Assembly of investigational medicinal products in hospitals and health centres
s.art007 Exemptions from prohibition on sale or supply of medicinal products not subject to general sale: two types of authorisation of a pharmacist
s.art008 Standards of conduct, ethics and performance related to authorisations
Part 3

Consequential Amendments

0 of 4 sections shown
4 other sections in this Part — procedural and definitional
s.art009 Consequential amendments to the Misuse of Drugs (Safe Custody) Regulations 1973
s.art010 Consequential amendments to the Misuse of Drugs Regulations 2001
s.art011 Consequential amendment to the Medicines for Human Use (Clinical Trials) Regulations 2004
s.art012 Consequential amendments to the Human Medicines Regulations 2012 and transitional provision

Duty extraction and severity labels are Guvnor’s analysis of the instrument, not the instrument itself. Always verify against the linked source text.